Go Back To Menu
Close
- Mailing Form
-
Medical Report*
-
Go Back To Menu
Rheumatoid arthritis treatment emphasizes comprehensive management, including medication, rehabilitation, and lifestyle interventions. Early intervention can effectively delay joint damage. In recent years, immune reconstruction cell therapy and stem cell therapy have become research hotspots, and when combined with traditional methods, they are expected to provide patients with more treatment options.
Europe and America
In Europe and America, the prevalence of rheumatoid arthritis is about 0.5%~1%, with a higher proportion of women. Due to abundant medical resources, patients generally receive standardized treatment at an early stage, and the rate of joint deformities has significantly decreased.
Southeast Asia
In Southeast Asia, patients often experience delayed diagnosis leading to worsening conditions. Humid climate, economic disparities, and limited healthcare accessibility contribute to higher disability rates compared to developed countries.
Immune reconstruction cell therapy reshapes the patient’s immune system, reducing abnormal immune responses that attack joints while promoting tissue repair. This method utilizes the synergistic effects of various immune cells to restore immune balance, enhance anti-inflammatory capacity, and potentially reduce long-term drug dependence.
1. Repairing the joint inflammatory environment
By suppressing pro-inflammatory cytokines, it reduces synovial inflammation, alleviating pain and swelling.
2. Promoting cartilage and bone tissue regeneration
It secretes multiple growth factors and signaling molecules to stimulate chondrocyte activity and help repair damaged bone tissue.
3. Improving immune function and quality of life
By rebalancing immune cells, it lowers relapse risks, allowing patients to achieve better quality of life and mobility.
In actual treatment, patients undergoing traditional regimens often face immune dysfunction, increased infection risks, and slow recovery. To help patients better sustain the treatment process, improve tolerance, and enhance quality of life, phased immune reconstruction programs must be scientifically designed for different cycles.
● Short-term plan: Rapidly boost immunity through immune cell reinfusion to strengthen anti-disease effects.
● Mid-term plan: Reduce side effects of conventional treatments, promote recovery, and ensure completion of standardized regimens.
● Long-term plan: Comprehensive enhancement of immunity through immune cell reconstruction, gut immunity restoration, elemental immunity rebuilding, and immune nutrition support, thereby improving quality of life and prolonging survival.
1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Relieve joint pain and inflammation, suitable for early symptom control, but gastrointestinal and cardiovascular side effects must be monitored.
2. Glucocorticoids
Rapidly suppress inflammation and are often used during acute flare-ups, but long-term use may cause osteoporosis and other complications.
3. Disease-Modifying Antirheumatic Drugs (DMARDs)
Such as methotrexate and leflunomide, which can slow disease progression and are one of the core medications in treatment.
4. Biologics
Target specific immune molecules, such as TNF-α inhibitors and IL-6 receptor antagonists, suitable for patients unresponsive to conventional DMARDs.
5. Targeted Synthetic DMARDs
Such as JAK inhibitors, administered orally, with rapid onset but requiring blood and liver function monitoring.
6. Physical Therapy and Rehabilitation
Through joint protection training, muscle strengthening, and physical modalities, joint mobility can be improved.
7. Surgery
For patients with severe joint deformities and functional loss, joint replacement or synovectomy may be performed.
8. Lifestyle Interventions
A balanced diet, regular exercise, smoking cessation, and limiting alcohol intake help control inflammation and enhance immunity.
Rheumatoid arthritis profoundly impacts patients’ quality of life. Chronic inflammation can lead to joint destruction and disability. Early standardized treatment, combined with emerging immune reconstruction cell therapy and traditional methods, is expected to significantly improve prognosis. Experts at United Life International Medical Center emphasize that comprehensive management and scientifically chosen treatment regimens will provide patients with longer-lasting health protection.
